Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review

Volume: 189, Pages: 106639 - 106639
Published: Nov 1, 2021
Abstract
Small airway disease is recognized as a cardinal pathological process of chronic obstructive pulmonary disease (COPD), and recently small airways have been recognized as a major site of airflow obstruction also in asthmatic patients. The transversal involvement of small airways in COPD and asthma has warranted research efforts to identify therapeutic strategies able to unlock the small airway compartment. The mainstay of COPD treatment is...
Paper Details
Title
Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review
Published Date
Nov 1, 2021
Volume
189
Pages
106639 - 106639
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.